All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 3302
Mikaela Naylon Give Kids a Chance Act of 2025
S 3971
Small Business Innovation and Economic Security Act

Lobbying activity 2

Health Issues

Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases.

Small Business

Issues related to the Small Business Innovation Research Program in S. 3971 - Small Business Innovation and Economic Security Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.